Circulating monocyte chemoattractant protein-1 and early development of nephropathy in type 1 diabetes

Diabetes Care

Volumn 25, Issue 10, 2002, Pages 1829-1834

  Chiarelli, Francesco ^a,b   Cipollone, Francesco ^a   Mohn, Angelika ^a   Marini, Matteo ^a   Iezzi, Annalisa ^a   Fazia, Maria ^a   Tumini, Stefano ^a   De Cesare, Domenico ^a   Pomilio, Mariapina ^a   Pierdomenico, Sante D ^a   Di Gioacchino, Mario ^a   Cuccurullo, Franco ^a   Mezzetti, Andrea ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b Policlinico   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA TOCOPHEROL; HEMOGLOBIN A1C; MALONALDEHYDE; MONOCYTE CHEMOTACTIC PROTEIN 1; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC NEPHROPATHY; EXCRETION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID PEROXIDATION; MICROALBUMINURIA; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; VITAMIN SUPPLEMENTATION; ADULT; ALBUMINURIA; BIOSYNTHESIS; BLOOD; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; REFERENCE VALUE; REGRESSION ANALYSIS; TIME;

ADULT; ALBUMINURIA; BIOLOGICAL MARKERS; CHEMOKINE CCL2; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPID PEROXIDATION; REFERENCE VALUES; REGRESSION ANALYSIS; TIME FACTORS; VITAMIN E;

EID: 0036781581     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.10.1829     Document Type: Article

References (29)

1. Messent JW, Elliott TG, Hill RD, Jarrett RJ, Keen H, Viberti GC: Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study. Kidney Int 41:836-839, 1992
2. Nathan D: Relationship between metabolic control and long term complications of diabetes. In Joslin's Diabetes Mellitus. 13th ed. Khan CR, Weir GC, Eds. Philadelphia, Lea & Febiger, 1994, p. 620-630
3. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
4. Mezzetti A, Cipollone F, Cuccurullo F: Oxidative stress and complications in diabetes: isoprostanes as new markers on an old paradigm (Review Article). Cardiovasc Res47:475-488, 2000
5. Walker JD, Close CF, Jones SL, Rafftery M, Keen H, Viberti G, Osterby R: Glomerular structure in type 1 (insulin-dependent) diabetic patients with normo- and microalbuminuria. Kidney Int 41:741-748, 1992
6. Furuta T, Saito T, Ootaka T, Soma J, Obara K, Abe K, Yoshinaga K: The role of macrophages in diabetic glomerulosclerosis. Am J Kidney Dis 21:480-485, 1993
7. Young BA, Johnson RJ, Alpers CE, Eng E, Gordon K, Floege J, Couser WG, Seidel K: Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int 47:935-944, 1995
8. Rollins BJ: Monocyte chemoattractant protein-1: a potent regulator of monocyte recruitment in inflammatory disease. Mol Med Today 2:198-204, 1996
9. Carr MW, Roth SJ, Luther E, Rose SS, Springer TA: Monocyte chemoattractant protein-1 acts as a T-lymphoyte chemoattractant. Proc Natl Acad Sci U S A 91:3652-3656, 1994
10. Cipollone F, Marini M, Fazia M, Pini B, Iezzi A, Reale M, Paloscia L, Materazzo G, D'Annunzio E, Conti P, Chiarelli F, Cuccurullo F, Mezzetti A: Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vasc Biol 21:327-334, 2001
11. Conti P, Pang X, Boucher W, Letourneau R, Reale M, Barbacane RC, Thibault J, Theoharides TC: Impact of Rantes and MCP-1 chemokines on in vivo mast cell recrutiment in rat skin injection model and their role in modifying the protein and mRNA levels for histidine decarboxylase. Blood 89:4120-4127, 1997
12. Ueda A, Okuda K, Ohno S, Shirai A, Igarashi T, Matsunaga K, Fukushima J, Kawamoto S, Ishigatsubo Y, Okubo T: NF-kB and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J Immunol 153:2052-2063, 1994
13. Takahara N, Kashiwagi A, Nishio Y, Harada N, Kojima H, Maegawa H, Hidaka H, Kikkawa R: Oxidized lipoproteins found in patients with NIDDM stimulate radical-induced monocyte chemoattractant protein-1 in RNA expression in cultured endothelial cells. Diabetologia 40:662-670, 1997
14. Cushing SD, Berliner JA, Valente AJ, Territo MC, Navab M, Parhami F, Gerrity R, Schwartz CJ, Fogelman AM: Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci U S A 87:5134-5138, 1990
15. Bian ZM, Elner SG, Strieter RM, Glass MB, Lukacs NW, Kunkel SL, Elner VM: Glycated serum albumin induces chemokine gene expression in human epithelial cells. J Leukoc Biol 60:405-414, 1996
16. Ihm CG, Park JK, Hong SP, Lee TW, Cho BS, Kim MJ, Cha DR, Ha H: A high glucose concentration stimulates the expression of monocytes chemotactic peptide 1 in human mesangial cells. Nephron 79:33-37, 1998
17. Mezzetti A, Guglielmi MD, Pierdomenico SD, Costantini F, Cipollone F, De Cesare D, Bucciarelli T, Ucchino S, Chiarelli F, Cuccurullo F, Romano F: Increased systemic oxidative stress after elective endoarteriectomy: relation to vascular healing and remodelling. Arterioscler Thromb Vasc Biol 19:2659-2665, 1999
18. Mezzetti A, Lapenna D, Pierdomenico SD, Calafiore AM, Costantini F, Riario-Sforza G, Imbastaro T, Neri M, Cuccurullo F: Vitamins E, C, and lipid peroxidation in plasma and arterial tissue of smokers and non-smokers. Atherosclerosis 112:91-99, 1995
19. Cattel V: Macrophages in acute glomerular inflammation. Kidney Int 45:945-952, 1994
20. Stahl RAK, Thaiss F, Disser M, Helmch U, Hora K, Schloendarff D: Increased expression of monocyte chemoattractant protein-1 in anti-thymocyte antibody induced glomerulonephritis. Kidney Int 44:1036-1047, 1993
21. Park I-S, Kiyomoto H, Abboud SL, Abboud HE: Expression of transforming growth factor-β and type IV collagen in early streptozotocin-induced diabetes. Diabetes 46:473-480, 1997
22. Ihm CG: Monocyte chemotactic peptide-1 in diabetic nephropathy. Kidney Int 52 (Suppl. 60):S20-S22, 1997
23. Banba N, Nakamura T, Matsumura M, Kuroda H, Hattori Y, Kasai K: Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy. Kidney Int 58:684-690, 2000
24. Ha H, Yoon SJ, Kim MJ: High glucose can induce lipid peroxidation in the isolated rat glomeruli. Kidney Int 46:1620-1626, 1994
25. Satriano J, Schloendorff D: Activation and attenuation of transcription factor NF-kB in mouse glomerular mesangial cells in response to tumor necrosis factor-alpha, immunoglobulin G, and adenosine 3′:5′-cyclic monophosphate: evidence for involvement of reactive oxygen species. J Clin Invest 94:1629-1636, 1994
26. Ishikawa Y, Sugiyama H, Stylianou E, Kitamura M: Bioflavonoid quercetin inhibits interleukin-1-induced transcriptional expression of monocyte chemoattractant protein-1 in glomerular cells via suppression of nuclear factor-kB. J Am Soc Nephrol 10:2290-2296, 1999
27. Marra F, DeFranco R, Grappone C, Parola M, Milani S, Leonarduzzi G, Pastacaldi S, Wenzel UO, Pinzani M, Dianzani MU, Laffi G, Gentilini P: Expression of monocyte chemotactic protein-1 precedes monocyte recruitment in a rat model of acute liver injury, and is modulated by vitamin E. J Investig Med 47:66-75, 1999
28. Gaede P, Poulsen HE, Parving HH, Pedersen O: Double-blind, randomised study of the effect of combined treatment with vitamin C and E on albuminuria in type 2 diabetic patients. Diabet Med 18:756-760, 2001
29. The Heart Outcomes Prevention Evaluation Study Investigators: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 355:253-259, 2000